Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic Patients
Clinical trial NCT00642421 · TERMINATED
Trial details
- NCT number
- NCT00642421
- Sponsor
- Ambrilia Biopharma, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-01
- Primary completion
- 2009-08-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.